Jakko Aaltonen
Articles
Monitoring of phase transformations during processing of solid dosage forms
April 1st 2007When a dosage form or an API is introduced to the gastrointestinal tract, or dissolution media mimicking it, a transformation from a metastable to a more stable form with lower solubility and bioavailability is possible.
Latest Updated Articles
Published: January 10th 2025 | Updated: January 13th 2025
Cavazzoni Retires as CDER Director
Published: October 11th 2024 | Updated: October 18th 2024
Buy, Sell, Hold: Cell and Gene Therapy - Part 1
Published: September 10th 2024 | Updated: September 18th 2024
CPHI Milan Announces 2024 CPHI Pharma Award Finalists
Published: December 23rd 2024 | Updated: January 21st 2025
Beyond Jet Milling: A Deep Dive into Carrier-Based Formulation and Process Optimization - Executive Summary
Published: March 3rd 2024 | Updated: January 21st 2025
Shining a Light on the Long Shadow of Subjectivity in Quality Risk Management
Published: January 3rd 2024 | Updated: January 21st 2025
Developing an Optimized Risk Assessment Portfolio—The Quality Risk Management Master Plan
